Trump Administration Bans Medicaid Funding for Minor Gender-Affirming Care Starting October 13
The Trump administration announced that federal Medicaid and CHIP funds will no longer cover gender transition surgeries or hormone therapies for minors, effective October 13. The policy, directed by CMS, excludes mental health services and allows a six-month transition for current patients. Critics and medical groups have condemned the move as an infringement on care.
The Trump administration announced on Tuesday, August 11, said that federal Medicaid and Children's Health Insurance Program (CHIP) funds will no longer cover gender transition surgeries or hormone therapies for minors. The new policy, which takes effect on October 13, marks a significant escalation in federal efforts to restrict access to gender-affirming healthcare for youth nationwide.
The directive, implemented through the Centres for Medicare & Medicaid Services (CMS), effectively prohibits the use of federal dollars for puberty-blocking medications, cross-s*x hormones, and surgical interventions for individuals under 18. Iran Threat: Donald Trump Secretly Flew From NATO Summit on Alternate Jet Over Assassination Fear.
Medicaid Will NO LONGER Fund Gender Transition Surgeries and Hormones for Minors
Presidential Directive and Administration Stance
President Donald Trump announced the decision via his Truth Social platform, framing the move as a protective measure for children. “We are not going to pay for our innocent children to undergo these barbaric surgeries and practices, which result in unthinkable and irreversible harm to their young bodies,” President Trump wrote. He further urged voters to consider the administration’s stance ahead of the upcoming midterm elections, contrasting his position with that of the Democratic Party, which he criticised for supporting such medical interventions. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. stated that the policy is intended to end taxpayer support for procedures he described as carrying “serious risks” and the potential for “irreversible harm.”
Implementation and Clinical Impact
CMS Administrator Dr Mehmet Oz, who was directed by the President to oversee the policy shift, emphasised that the administration prioritises what he termed “experimental interventions” as a point of concern. “By cutting off federal funds for these s*x-rejecting procedures, we're following the science, saving taxpayer dollars, and, most importantly, protecting children from potentially irreversible harm so they can truly flourish,” Dr Oz stated.
Key details regarding the rule’s implementation include:
- Effective Date: The policy takes effect nationwide on October 13, 2026.
- Transition Period: Children currently receiving hormone therapy will be granted a six-month period of continued federal funding to facilitate a transition in care.
- Mental Health Coverage: Standard mental health services for transgender youth will remain unaffected by the new rule.
- State Autonomy: States that wish to continue providing gender-affirming care through Medicaid or CHIP may do so, but they must do so using independent state funds rather than federal contributions. Donald Trump Warns FIFA Against Replacing Embattled President Gianni Infantino.
Opposition and Legal Context
The administration’s announcement has drawn immediate condemnation from LGBTQ+ advocacy groups and major medical associations. Organisations including the Human Rights Campaign and The Trevor Project have criticised the rule as an infringement on doctor-prescribed, evidence-based care. Legal experts anticipate immediate challenges to the policy. While at least 27 states have already implemented their own bans on gender-affirming care for minors, federal courts have previously signalled scepticism toward broader executive attempts to unilaterally restrict healthcare access. Earlier this year, a federal judge struck down an effort by HHS Secretary Kennedy to threaten hospital funding based on similar policy declarations, ruling that the agency had exceeded its legal authority.
Most major medical organisations, including the American Academy of Paediatrics, maintain that gender-affirming care is medically necessary and should be determined within the patient-physician relationship.
(The above story first appeared on LatestLY on Aug 12, 2026 07:16 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).